Y-mAbs Therapeutics - 48 Year Dividend History | YMAB

Historical dividend payout and yield for Y-mAbs Therapeutics (YMAB) since 1971. The current TTM dividend payout for Y-mAbs Therapeutics (YMAB) as of June 18, 2019 is $0.00. The current dividend yield for Y-mAbs Therapeutics as of June 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.711B $0.000B
Y-mAbs Therapeutics Inc. is a biopharmaceutical company. It focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The company's product pipeline consists of naxitamab and omburtamab which are in clinical stage. Y-mAbs Therapeutics Inc. is based in NEW YORK, USA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $85.546B 10.39
Bio-Techne Corp (TECH) United States $7.848B 53.55